ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
ORAMED PHARMACEUTICALS INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$4.06−0.01 (-0.25%)
Close on Oct 19, 2026
- Market cap
- $172.56M
- P/E (TTM)
- 1.0
- Dividend yield
- 6.16%
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
$0.25
Consecutive increases
0 years
Not raised last year
Dividend yield
6.16%
Latest annual dividend ÷ share price
Payout ratio, FY2025
–
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | $0.25 | – | – | – |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.